Shopping Cart
Remove All
Your shopping cart is currently empty
NF-κB-IN-15 (compound 14r) is a potent NF-κB inhibitor. It reduces NO levels in LPS-stimulated cells and suppresses the release of IL-6, TNF-α, and IL-1β. Additionally, it hinders LPS-induced p65 phosphorylation and IκBα degradation. NF-κB-IN-15 exhibits anti-inflammatory properties and holds potential for research in acute lung injury (ALI).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | NF-κB-IN-15 (compound 14r) is a potent NF-κB inhibitor. It reduces NO levels in LPS-stimulated cells and suppresses the release of IL-6, TNF-α, and IL-1β. Additionally, it hinders LPS-induced p65 phosphorylation and IκBα degradation. NF-κB-IN-15 exhibits anti-inflammatory properties and holds potential for research in acute lung injury (ALI). |
| In vitro | NF-κB-IN-15 (compound 14r) reduces NO levels in a dose-dependent manner and inhibits IL-6, TNF-α, and IL-1β in LPS-induced RAW 264.7 cells when applied at concentrations of 1.25, 2.5, 5, 10, and 20 µM for 1+24 hours. Additionally, NF-κB-IN-15 at 10 and 20 µM for 1+4 hours suppresses LPS-induced p65 phosphorylation and IκBα degradation. |
| In vivo | NF-κB-IN-15 (compound 14r) (20 mg/kg; i.p.) demonstrates anti-inflammatory effects in mice with acute lung injury (ALI). |
| Formula | C46H58N4O8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.